Break-through Infection Following Mpox vaccinatIon

Summary

The purpose of this study is to assess the protection of smallpox preexposure vaccination against infection with mpox in real-world individuals with risk factors for mpox.

Conditions

• Mpox

Interventions

DRUG

Mpox Vaccine

Vaccination with smallpox and mpox vaccine (Live Modified Vaccinia Virus Ankara)

Sponsors & Collaborators

• Department of Health, Generalitat de Catalunya

  collaborator OTHER_GOV

• Hospital Vall d'Hebron

  collaborator OTHER

• Hospital Clinic of Barcelona

  collaborator OTHER

• Hospital Universitario 12 de Octubre

  collaborator OTHER

• Public Health Service of Madrid

  collaborator OTHER

• Madrid Salud

  collaborator OTHER

• Harvard School of Public Health (HSPH)

  collaborator OTHER

• London School of Hygiene and Tropical Medicine

  collaborator OTHER

• Germans Trias i Pujol Hospital

  collaborator OTHER

• BCN Checkpoint

  collaborator INDUSTRY

• Centro de Saluld Sandoval

  collaborator UNKNOWN

• Centro de Salud Montesa

  collaborator UNKNOWN

• Hospital Nacional Arzobispo Loayza

  collaborator OTHER

• Hospital Regional III Honorio Delgado

  collaborator UNKNOWN

• Hospital Regional Docente de Trujillo

  collaborator UNKNOWN

• Instituto Conmemorativo Gorgas de Estudios de la Salud

  collaborator UNKNOWN

• Ministerio de Salud de Panamá

  collaborator UNKNOWN

• Fundación Arriaran

  collaborator UNKNOWN

• Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

  lead OTHER

Eligibility

Min Age

18 Years

Sex

MALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2022-09-12

Primary Completion

2024-03-30

Completion

2024-03-30

Countries

• Chile
• Panama
• Peru
• Spain

Study Locations